X.T.L. Biopharmaceuticals Ltd. - ADR
XNAS: XTLB
X.T.L. Biopharmaceuticals Ltd. - ADR Live Stock Price Today, Share Analysis and Chart
about
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a m...
Read More
1.18
-0.01
(-0.84%)
1,332
XNAS Volume
XNAS 03 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for X.T.L. Biopharmaceuticals Ltd. - ADR is on 05 Sep 2025 for the purpose of XTL Biopharmaceuticals Ltd Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
X.T.L. Biopharmaceuticals ... Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..